Santen Pharmaceutical Co., Ltd.
TSE:4536.T
Overview | Financials
Company Name | Santen Pharmaceutical Co., Ltd. |
Symbol | 4536.T |
Currency | JPY |
Price | 1,749 |
Market Cap | 622,035,234,315 |
Dividend Yield | 2.05% |
52-week-range | 1,255 - 1,878.5 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Takeshi Ito |
Website | https://www.santen.com |
An error occurred while fetching data.
About Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD